Literature DB >> 15977084

Migraine: traditional or "innovative" treatment? A preliminary case-control study.

E Morandi1, G P Anzola, F Casilli, E Onorato.   

Abstract

The aim of this preliminary case-control study was to compare, in patients with migraine and PFO, transcatheter closure of PFO vs. medical treatments. Twelve patients were treated with antimigraine drugs and twelve underwent percutaneous transcatheter closure. All patients were followed-up for 12 months. Our preliminary results seem to confirm that, compared to medical treatment, PFO closure is by far more effective in reducing both frequency, duration and intensity of migraine attacks. Furthermore, the occurrence of prodromal aura is almost abolished.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15977084     DOI: 10.1007/s00246-005-1006-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

Review 1.  Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography.

Authors:  M Jauss; E Zanette
Journal:  Cerebrovasc Dis       Date:  2000 Nov-Dec       Impact factor: 2.762

2.  Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine.

Authors:  Martijn C Post; Vincent Thijs; Luc Herroelen; Werner I H L Budts
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

3.  Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.

Authors:  W F Stewart; R B Lipton; D D Celentano; M L Reed
Journal:  JAMA       Date:  1992-01-01       Impact factor: 56.272

4.  Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism.

Authors:  D J Ende; P S Chopra; P S Rao
Journal:  Am J Cardiol       Date:  1996-07-15       Impact factor: 2.778

Review 5.  An update on the epidemiology of migraine.

Authors:  R B Lipton; S D Silberstein; W F Stewart
Journal:  Headache       Date:  1994-06       Impact factor: 5.887

6.  Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study.

Authors:  G P Anzola; M Magoni; M Guindani; L Rozzini; G Dalla Volta
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

7.  Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks.

Authors:  M Schwerzmann; S Wiher; K Nedeltchev; H P Mattle; A Wahl; C Seiler; B Meier; S Windecker
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

8.  Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial).

Authors:  H Sievert; U U Babic; G Hausdorf; M Schneider; H W Höpp; D Pfeiffer; M Pfisterer; B Friedli; P Urban
Journal:  Am J Cardiol       Date:  1998-12-01       Impact factor: 2.778

9.  Migraine as a risk factor for subclinical brain lesions.

Authors:  Mark C Kruit; Mark A van Buchem; Paul A M Hofman; Jacobus T N Bakkers; Gisela M Terwindt; Michel D Ferrari; Lenore J Launer
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

10.  Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study.

Authors:  M Del Sette; S Angeli; M Leandri; G Ferriero; G L Bruzzone; C Finocchi; C Gandolfo
Journal:  Cerebrovasc Dis       Date:  1998 Nov-Dec       Impact factor: 2.762

View more
  2 in total

Review 1.  Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis.

Authors:  Yu-Jie Shi; Jun Lv; Xing-Ting Han; Guo-Gang Luo
Journal:  BMC Cardiovasc Disord       Date:  2017-07-26       Impact factor: 2.298

Review 2.  Association of migraine with patent foramen ovale closure: A systematic review and meta-analysis.

Authors:  Yan-Li Wang; Fang-Ze Wang; Yuan Zhang; Jiwei Jiang; Ziyan Jia; Xiangrong Liu; Jian Wang; Jun Xu
Journal:  Int J Cardiol Heart Vasc       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.